RAMALLAH: Israel said on Monday it supplied the Palestinians with their first shipment of COVID-19 shots, totalling 2,000 doses of Moderna’s vaccine.
The vaccines were transferred into the occupied West Bank and will be used by Palestinian Authority medical teams, according to a statement by COGAT, Israel’s military liaison to the Palestinians.
Palestinian officials declined to confirm or deny the delivery.
Israel has earmarked an additional 3,000 doses for the Palestinians, said a COGAT spokesman.
Israel has emerged as a world leader in vaccinating its citizens and the Palestinian Authority has separately been trying to secure its own doses. It has ordered a batch of Russia’s Sputnik V vaccine.
The Palestinians will also be receiving upwards of 35,000 to 40,000 vaccines from the COVAX global vaccine sharing program in the coming weeks, a World Health Organization official said on Monday.
Israel captured the West Bank in the 1967 Middle East war. Palestinians seek the territory for an independent state they hope to set up in the West Bank, Gaza and East Jerusalem.
Israel says supplied first COVID-19 vaccines to Palestinians
Short Url
https://arab.news/nahsa
Israel says supplied first COVID-19 vaccines to Palestinians
- Israel has earmarked an additional 3,000 doses for the Palestinians
EU chief says bloc ‘stands fully behind’ Iran protesters
- “Europe stands fully behind them,” von der Leyen posted online
BRUSSELS: EU chief Ursula von der Leyen on Saturday said Europe backed Iranians’ mass protests and condemned the “violent repression” against the demonstrators.
“Tehran’s streets, and cities around the world, echo with the footsteps of Iranian women and men demanding freedom. Freedom to speak, to gather, to travel and above all to live freely. Europe stands fully behind them,” von der Leyen, head of the European Commission, posted online.
“We unequivocally condemn the violent repression of these legitimate demonstrations. Those responsible will be remembered on the wrong side of history,” she added.
© 2026 SAUDI RESEARCH & PUBLISHING COMPANY, All Rights Reserved And subject to Terms of Use Agreement.










